Identification of a novel gene fusion (BMX-ARHGAP) in gastric cardia adenocarcinoma

Diagn Pathol. 2014 Dec 13:9:218. doi: 10.1186/s13000-014-0218-4.

Abstract

Background: Gastric cardia adenocarcinoma (GCA) is one of the major causes of cancer related mortality worldwide. We aim to provide new understanding in the pathogenesis of GCA through investigations on gene expression alterations.

Methods: We preformed RNA-Seq for one pair of GCA and matched non-tumor tissues. Differentially expressed genes (DEGs) and fusion genes were acquired. PCR and gel analysis in additional 14 pairs of samples were performed to validate the chimeric transcripts.

Results: 1590 up-regulated and 709 down-regulated genes were detected. Functional analysis revealed that these DEGs were significantly overrepresented in gene ontology items of cell cycle, tumor invasion and proliferation. Moreover, we firstly discovered 3 fusion genes in GCA, including BMX-ARHGAP, LRP5- LITAF and CBX3-C15orf57. The chimeric transcript BMX-ARHGAP was validated and recurrently occurred in 4/15 independent tumor tissues.

Conclusions: Our results may provide new understanding of GCA and biomarkers for further therapeutic studies.

Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/13000_2014_218.

MeSH terms

  • Adenocarcinoma / genetics*
  • Adenocarcinoma / pathology
  • Aged
  • Biomarkers, Tumor / genetics*
  • Cardia / chemistry*
  • Cardia / pathology
  • Gene Expression Profiling / methods
  • Gene Expression Regulation, Neoplastic
  • Gene Fusion*
  • Genetic Association Studies
  • Humans
  • Male
  • Oncogene Fusion / genetics
  • Polymerase Chain Reaction
  • Predictive Value of Tests
  • RNA, Messenger / genetics
  • Reproducibility of Results
  • Stomach Neoplasms / genetics*
  • Stomach Neoplasms / pathology

Substances

  • Biomarkers, Tumor
  • RNA, Messenger